Kleer CG - Search Results

1

EZH2 T367 phosphorylation activates p38 signaling through lysine methylation to promote breast cancer progression.

Gonzalez ME, Naimo GD, Anwar T, Paolì A, Tekula SR, Kim S, Medhora N, Leflein SA, Itkin J, Trievel R, Kidwell KM, Chen YC, Mauro L, Yoon E, Andò S, Kleer CG. Gonzalez ME, et al. Among authors: kleer cg. iScience. 2022 Aug 2;25(8):104827. doi: 10.1016/j.isci.2022.104827. eCollection 2022 Aug 19. iScience. 2022. PMID: 35992062 Free PMC article.

2

Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.

Privette LM, González ME, Ding L, Kleer CG, Petty EM. Privette LM, et al. Among authors: kleer cg. Cancer Res. 2007 Jul 1;67(13):6064-74. doi: 10.1158/0008-5472.CAN-06-4109. Epub 2007 Jun 27. Cancer Res. 2007. PMID: 17596595 Free article.

3

Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.

Gonzalez ME, Li X, Toy K, DuPrie M, Ventura AC, Banerjee M, Ljungman M, Merajver SD, Kleer CG. Gonzalez ME, et al. Among authors: kleer cg. Oncogene. 2009 Feb 12;28(6):843-53. doi: 10.1038/onc.2008.433. Epub 2008 Dec 15. Oncogene. 2009. PMID: 19079346 Free PMC article.

4

Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.

Li X, Gonzalez ME, Toy K, Filzen T, Merajver SD, Kleer CG. Li X, et al. Among authors: kleer cg. Am J Pathol. 2009 Sep;175(3):1246-54. doi: 10.2353/ajpath.2009.090042. Epub 2009 Aug 6. Am J Pathol. 2009. PMID: 19661437 Free PMC article.

5

Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells.

Huang W, Gonzalez ME, Toy KA, Banerjee M, Kleer CG. Huang W, et al. Among authors: kleer cg. Cancer Res. 2010 Apr 15;70(8):3340-50. doi: 10.1158/0008-5472.CAN-09-4225. Cancer Res. 2010. PMID: 20395207 Free PMC article.

6

Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.

Gonzalez ME, DuPrie ML, Krueger H, Merajver SD, Ventura AC, Toy KA, Kleer CG. Gonzalez ME, et al. Among authors: kleer cg. Cancer Res. 2011 Mar 15;71(6):2360-70. doi: 10.1158/0008-5472.CAN-10-1933. Cancer Res. 2011. PMID: 21406404 Free PMC article.

7

EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.

Moore HM, Gonzalez ME, Toy KA, Cimino-Mathews A, Argani P, Kleer CG. Moore HM, et al. Among authors: kleer cg. Breast Cancer Res Treat. 2013 Apr;138(3):741-52. doi: 10.1007/s10549-013-2498-x. Epub 2013 Mar 29. Breast Cancer Res Treat. 2013. PMID: 23539298 Free PMC article.

8

Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer.

Anwar TE, Kleer CG. Anwar TE, et al. Among authors: kleer cg. Hum Pathol. 2013 Aug;44(8):1457-64. doi: 10.1016/j.humpath.2013.01.005. Epub 2013 Apr 8. Hum Pathol. 2013. PMID: 23574782 Free PMC article. Review.

9

EZH2 expands breast stem cells through activation of NOTCH1 signaling.

Gonzalez ME, Moore HM, Li X, Toy KA, Huang W, Sabel MS, Kidwell KM, Kleer CG. Gonzalez ME, et al. Among authors: kleer cg. Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3098-103. doi: 10.1073/pnas.1308953111. Epub 2014 Feb 10. Proc Natl Acad Sci U S A. 2014. PMID: 24516139 Free PMC article.

10

Characterization of type III TGF-β receptor expression in invasive breast carcinomas: a potential new marker and target for triple negative breast cancer.

Pang JC, Virani NK, Kidwell KM, Kleer CG. Pang JC, et al. Among authors: kleer cg. J Cell Commun Signal. 2014 Sep;8(3):211-8. doi: 10.1007/s12079-014-0240-z. Epub 2014 Aug 19. J Cell Commun Signal. 2014. PMID: 25135009 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page